TBRC’s market research report covers hyaluronic acid-based dermal fillers market size, hyaluronic acid-based dermal fillers market forecasts, major hyaluronic acid-based dermal fillers companies and their market share, key strategies to undertake, and more.
LONDON, Aug. 17, 2022 (GLOBE NEWSWIRE) — According to The Business Research Company’s research report on the hyaluronic acid-based dermal fillers market, increasing demand for non-invasive dermatology techniques is driving the growth of hyaluronic acid-based dermal fillers. Deep palpation, x-rays, and blood pressure checks are examples of non-invasive tests that require breaking the skin or entering the body. Most of the treatments are non-invasive and are done by using acid-based dermal fillers as they have minimal risks involved and give long-lasting results. For example, The American Society of Plastic Surgeons (ASPS), a society for American plastic surgeons, stated in February 2022 that each year, more than 17 million adults opt for cosmetic surgeries that include minimally invasive options such as body contouring, lasers, and injections. This demand is expected to drive the hyaluronic acid-based dermal fillers market.
Request for a sample of the global hyaluronic acid-based dermal fillers market report
The global hyaluronic acid-based dermal fillers market size is expected to grow from $3.58 billion in 2021 to $3.91 billion in 2022 at a compound annual growth rate (CAGR) of 9.5%. The global hyaluronic acid-based dermal fillers market share is expected to grow to $5.66 billion in 2026 at a CAGR of 9.7%.
Technological advancements are shaping the hyaluronic acid-based dermal fillers market. Major companies operating in the hyaluronic acid-based dermal fillers sector are focused on developing new technological solutions to strengthen their position in the hyaluronic acid-based dermal fillers market. For instance, in 2021, a new treatment called laser resurfacing treatments was introduced on the market, which is more efficient and less invasive, addressing multiple skin concerns. It uses lasers to solve all the skin problems at once, making them more appealing. Moreover, the treatment can also be used to cope with COVID-19 stress.
As per the hyaluronic acid-based dermal fillers industry report, major players in the hyaluronic acid-based dermal fillers market are Bohus Biotech AB, Allergan, Galderma Laboratories L.P, Merz Pharmaceuticals, Genzyme Corporation, Anika Therapeutics Inc, LG Life Sciences, Bio plus Co. Ltd., Sculpt Luxury Dermal Fillers Ltd, Bioxis Pharmaceutical, Sinclair Pharma, Laboratories Vivacy, Medicis Aesthetics Holdings, Inc., and Inamed Corp.
The global hyaluronic acid-based dermal fillers market analysis is segmented by product into single-phase product, duplex product; by usage into speciality and dermatology clinics, hospitals and clinics; by application: into wrinkle removal, lip augmentation, rhinoplasty, others.
North America was the largest region in the hyaluronic acid-based dermal fillers market in 2021. Asia-Pacific is expected to be the fastest-growing region in the global hyaluronic acid-based dermal fillers market during the forecast period. The regions covered in the global hyaluronic acid-based dermal fillers market overview are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Hyaluronic Acid-Based Dermal Fillers Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provide hyaluronic acid-based dermal fillers market overviews, hyaluronic acid-based dermal fillers market analyze and forecast market size and growth for the whole market, hyaluronic acid-based dermal fillers market segments and geographies, hyaluronic acid-based dermal fillers market trends, hyaluronic acid-based dermal fillers market drivers, hyaluronic acid-based dermal fillers market restraints, hyaluronic acid-based dermal fillers market leading competitors’ revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.
The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Not the market you are looking for? Check out some similar market intelligence reports:
Dermal Filler Global Market Report 2022 – By Filler Type (Calcium Hydroxylapatite, Hyaluronic Acid, Poly-Alkylimide, Polylactic Acid, Polymethylmethacrylate Microspheres), By Product (Biodegradable, Non-Biodegradable), By End-User (Hospital, Cosmetic Clinics, Outpatient Centres, Beauty Centres, Other End-Users), By Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration Of Volume Or Fullness) – Market Size, Trends, And Global Forecast 2022-2026
Cosmetic Surgery Global Market Report 2022 – By Procedure Type (Surgical Procedures, Non-Surgical Procedures, Other Procedures), By Provider (Spas And Cosmetic Surgery Centers, Hospitals And Specialty Clinics), By Gender (Male, Female), By Application (Liposuction, Eyelid And Nose Surgery, Body Contouring, Face Reconstruction, Cosmetic Implants, Other Applications), By End-User (Hospitals, Surgical Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2022-2026
Aesthetic Medicine Global Market Report 2022 – By Product (Facial Aesthetic Products, Body Contouring Devices, Cosmetic Implants, Hair Removal Devices, Skin Aesthetic Devices, Tattoo Removal Devices, Thread Lift Products, Physician-Dispensed Cosmeceuticals And Skin Lighteners, Physician-Dispensed Eyelash Products, Nail Treatment Laser Devices), By Procedure Type (Invasive Procedures, Non-Invasive Procedures), By End-User (Clinics, Hospitals, And Medical Spas, Beauty Centres, Home Care) – Market Size, Trends, And Global Forecast 2022-2026
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
The meme-stock crowd is backing AMC Entertainment again, but shareholders should probably be upset by the latest developments.
Scott Burg, the chief investment officer of Deer Park Road Management Co, who made the prediction that Tesla would be "squashed like a bug" in a 2020 tweet, bought put options on almost 4.8 million Tesla shares during the second quarter, according to a regulatory filing this week, Bloomberg and Barron's reported.
These are two of the most dominant companies on the stock market, and you can buy them at a discount.
In the first quarter of the year, Warren Buffett and his company Berkshire Hathaway initiated a small stake in the digital consumer bank Ally Financial (NYSE: ALLY), which is also a big auto lender. In the second quarter of the year, Berkshire more than tripled its position in the stock, purchasing more than 21 million shares in the quarter. With Buffett and Berkshire buying heavily now, is Ally a buy?
The Federal Reserve’s Jackson Hole conference takes place this week. Plus, manufacturing and services PMIs and earnings from Zoom, Nvidia, Salesforce, Snowflake, and more.
Strategists at Citi Research say the current bear-market rally is in line with the length of an average bear-market bounce, and sentiments improved as much as it typically does. These signs suggest a possible end soon.
(Bloomberg) — Some of Asia’s biggest funds more than doubled their positions in Alibaba Group Holding Ltd. and Sea Ltd. in the second quarter after a yearlong rout. Most Read from BloombergUkraine Latest: Russian Diplomat Sees No Mediated End to WarUS Mortgage Lenders Are Starting to Go BrokePowell Has Chance to Reset Market Expectations at Jackson HoleRecession Fears Set to Split Stocks and Bonds After Summer RallySeized Superyacht to Be Auctioned to Pay JPMorgan LoanThe number of Alibaba shar
The pandemic isn’t over. These stocks could pop again.
July and August were good months for equity bulls. But the bears might soon retake the upper hand, one Wall Street strategist warned.
Numerous companies and organizations are working to make the metaverse the next iteration of the internet, a place to interact with others digitally, explore new worlds, play some games, and/or hang out with friends. Several technology companies are already fighting to be king of the virtual hill, and two of them — Nvidia (NASDAQ: NVDA) and Apple (NASDAQ: AAPL) — are likely to have an outsized influence on the metaverse market, whatever it ends up being. Close your eyes for a moment and picture what you think the metaverse will look like.
Don’t suffer through the downturn. Take advantage of it, instead.
Axsome Therapeutics (NASDAQ: AXSM) stock recently shot higher on a generally lousy day for the overall stock market. The gains came in response to the FDA's approval of Auvelity, the first new line of treatment in years for millions of Americans with major depressive disorder. Does the FDA's approval of Axsome Therapeutics' first drug make this a smart stock to buy now?
Warren Buffett and his company Berkshire Hathaway have invested in a few initial public offerings in recent years.
Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on three names. While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names. Horizon Therapeutics PLC recently was downgraded to Hold with a C+ rating by TheStreet's Quant Ratings.
TOKYO (Reuters) -Oil prices slumped on Monday, ending three days of gains, as investors were concerned aggressive U.S. interest rate hikes will weaken the global economy and dent fuel demand while a strengthening dollar also added to pressure. Brent crude futures for October settlement declined $1.20, or 1.2%, to $95.52 a barrel by 0458 GMT. U.S. West Texas Intermediate (WTI) crude futures for September delivery, due to expire on Monday, were down $1.24, or 1.4%, at $89.53 a barrel.
Tesla's stock split will take place after the close of trading on Aug. 24, but don't expect to wake up to riches overnight.
The U.S. dollar is on the upswing again and headed toward the year-to-date highs seen in mid-July following a period of relative dormancy for the last month.
The first six months of 2022 were the worst the stock market has had in more than 40 years, officially entering a bear market on June 13. Despite some recent bouncebacks, investors remain worried. So much so that some have … Continue reading → The post Is the Stock Market Going to Crash in 2022? appeared first on SmartAsset Blog.
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the…
Novavax (NASDAQ: NVAX) is one of my favorite stocks. Sometimes you'll hear the advice, "Don't fall in love with your stocks." I used to believe that, but now I think it's fine to love your stocks. Did I love Novavax when it went up 3,000% for me in 2020? Yes, I did.
